-
281por Choi, Ji-in Vivien, Tchernookova, Boriana K., Kumar, Wasan, Kiedrowski, Lech, Goeke, Calla, Guizzetti, Marina, Larson, John, Kreitzer, Matthew A., Malchow, Robert Paul“…Adenosine failed to elicit any change in extracellular H(+) fluxes, and ATP-mediated increases in H(+) flux were inhibited by the P2 inhibitors suramin and PPADS suggesting direct activation of ATP receptors. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
282por McCoy, Kevin, Gudapati, Sateesh, He, Lawrence, Horlander, Elaina, Kartchner, David, Kulkarni, Soham, Mehra, Nidhi, Prakash, Jayant, Thenot, Helena, Vanga, Sri Vivek, Wagner, Abigail, White, Brandon, Mitchell, Cassie S.“…Examples of highly ranked predicted links to SARS-CoV-2: human leukocyte interferon, recombinant interferon-gamma, cyclosporine, antiviral therapy, zidovudine, chloroquine, vaccination, methotrexate, artemisinin, alkaloids, glycyrrhizic acid, quinine, flavonoids, amprenavir, suramin, complement system proteins, fluoroquinolones, bone marrow transplantation, albuterol, ciprofloxacin, quinolone antibacterial agents, and hydroxymethylglutaryl-CoA reductase inhibitors. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
283por Mahmood, Abid, Munir, Rubina, Zia-ur-Rehman, Muhammad, Javid, Noman, Shah, Syed Jawad Ali, Noreen, Lubna, Sindhu, Tayyaba Allamgir, Iqbal, Jamshed“…Compounds 6a and 6c exhibited selective inhibition for h-P2X7 receptor, whereas 6e, 7a, and 7b expressed selective inhibitions toward h-P2X2 receptor that were comparable to the positive control suramin and pyridoxalphosphate-6-azophenyl-2′,4′-disulfonic acid (PPADS).…”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
284por Zizzo, Maria Grazia, Cicio, Adele, Raimondo, Stefania, Alessandro, Riccardo, Serio, Rosa“…Nω–nitro‐l‐arginine methyl ester (L‐NAME), nitric oxide (NO) synthase inhibitor abolished the inhibitory responses in old preparations, but a residual responses persisted in young preparations, which in turn was abolished by suramin, purinergic receptor antagonist. α3–GABAA receptor subunit expression tends to change in an age‐dependent manner. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
285por Sammons, Rachel M., Bohanon, Amanda L., Kowtha, Anvith, Dejong, Audrey, Cho, Eun Jeong, Kaoud, Tamer S., Dalby, Kevin N.“…Two compounds identified in the screen, oleic acid and suramin, blocked the attachment of S-614G to ACE2 and S protein-driven cell entry into Calu-3 and ACE2-overexpressing HEK293T cells. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
286“…As with ATP-evoked P2XR7 currents, histone-evoked currents were inhibited by non-selective P2XR7 antagonists (Suramin, PPADS, and TNP-ATP). Selective P2XR7 antagonists, AZ10606120, A438079, GW791343, and AZ11645373, inhibited ATP-evoked P2XR7 currents but did not inhibit histone-evoked P2XR7 currents. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
287“…Compared with calcitriol, the antifibrotic agent suramin could inhibit fibroblast/myofibroblast proliferation and suppress the expression of TCF-4, which regulates fibrogenic determination. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
288“…Pre-treatment of these cells with suramin or mild acid stripping failed to expose receptors which may have been occupied by endogenously produced ligand. …”
Enlace del recurso
Enlace del recurso
Texto -
289Publicado 1994“…The sis-E1 constructs, targeted to the early Golgi complex, exhibited no proteolytic processing whereas the mutant forms of sis-E1 exhibited normal proteolytic processing. Treatment with suramin, a polyanionic compound that disrupts ligand/receptor interactions at the cell surface, was able to revert the transformed phenotype induced by the mutant sis-E1 constructs described here. …”
Enlace del recurso
Enlace del recurso
Texto -
290“…[Ca(2+)](i) transients induced by 2-MeSADP and UDP were antagonized by suramin (100 µM), U73122 (2 µM, PLC inhibitor), and 2-APB (10 or 30 µM, IP(3) receptor antagonist), but neither by staurosporine (1 µM, PKC inhibitor) nor depletion of extracellular Ca(2+). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
291“…Currents in dP2XB and dP2XE were strongly inhibited by Na(+) but insensitive to copper and the P2 receptor antagonists pyridoxal phosphate-6-azophenyl-2′,4′-disulfonic acid and suramin. Unusual for P2X channels, dP2XA and dP2XB were also Cl(−)-permeable. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
292por Mason, R Preston, Jacob, Robert F, Corbalan, J Jose, Szczesny, Damian, Matysiak, Kinga, Malinski, Tadeusz“…METHODS: Using amperometric NO and peroxynitrite (ONOO(-)) nanosensors, β(3)-receptor (agonist: L-755,507; antagonists: SR59230A and L-748,337), ATP efflux (the mechanosensitive ATP channel blocker, gadolinium) and P2Y-receptor (agonists: ATP and 2-MeSATP; antagonist: suramin) modulators, superoxide dismutase and a NADPH oxidase inhibitor (VAS2870), we evaluated the kinetics and balance of NO and ONOO(-) stimulated by nebivolol in human umbilical vein endothelial cells (HUVECs). …”
Publicado 2013
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
293por Schilling, Justin, Loziuk, Philip L., Muddiman, David C., Daniels, Harry V., Reading, Benjamin J.“…Affinity purification coupled to tandem mass spectrometry using highly purified VtgC as a bait protein revealed a single specific interacting protein (Y-box binding protein 2a-like [Ybx2a-like]) that eluted with suramin buffer and confirmed that VtgC does not bind the ovary vitellogenin receptors (LR8 and Lrp13). …”
Publicado 2015
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
294“…Revealed cardiotropic effects of NAD+ are likely to be mediated by P2 purine receptors, since P1 blocker DPCPX failed to affect them and P2 antagonist suramin abolished NAD + −induced alterations of electrical activity. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
295por Stupnikov, Alexey, O’Reilly, Paul G., McInerney, Caitriona E., Roddy, Aideen C., Dunne, Philip D., Gilmore, Alan, Ellis, Hayley P., Flannery, Tom, Healy, Estelle, McIntosh, Stuart A., Savage, Kienan, Kurian, Kathreena M., Emmert-Streib, Frank, Prise, Kevin M., Salto-Tellez, Manuel, McArt, Darragh G.“…Target compounds lost included candidate compounds of potential clinical utility in glioma (eg, suramin, dasatinib). Lost connections may have been linked to low-abundance genes in the gene signature that closely characterized the disease phenotype. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
296“…Simultaneous addition of a GM-CSF inhibitor, suramin, alleviated the HCEC impairment induced by PM2.5. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
297por Loser, Dominik, Schaefer, Jasmin, Danker, Timm, Möller, Clemens, Brüll, Markus, Suciu, Ilinca, Ückert, Anna-Katharina, Klima, Stefanie, Leist, Marcel, Kraushaar, Udo“…This included receptor sub-typing and the characterization of the anti-parasitic drug suramin as modulator of the cellular response to ATP. …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
298por Bunch, Thomas A., Guhathakurta, Piyali, Lepak, Victoria C., Thompson, Andrew R., Kanassatega, Rhye-Samuel, Wilson, Anna, Thomas, David D., Colson, Brett A.“…Using this reduction in lifetime as a readout of actin binding, a high-throughput screen of a 1280-compound library identified three reproducible hit compounds (suramin, NF023, and aurintricarboxylic acid) that reduced C0-C2 binding to actin in the micromolar range. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
299“…The plateau response of contraction was almost abolished by the purinoceptor antagonist suramin. These results suggest that there is a relatively minor early α(1D)-adrenoceptor and a larger early α(1A)-adrenoceptor component to stimulation-evoked contractions of mouse vas deferens, but the major α(1)-adrenoceptor component is revealed by prazosin to be α(1B)-adrenoceptor mediated. α(1B)-Adrenoceptor activation probably facilitates contractions mediated by other α(1)-adrenoceptors and by purinoceptors. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
300por Morales-Jiménez, Camilo, Balanta-Melo, Julián, Arias-Calderón, Manuel, Hernández, Nadia, Gómez-Valenzuela, Fernán, Escobar, Alejandro, Jaimovich, Enrique, Buvinic, Sonja“…Exogenous ATP increased the protein synthesis rate in FDB muscle 2.2-fold; this effect was blocked by Suramin (general P2X/P2Y antagonist), LY294002 (phosphatidylinositol 3 kinase inhibitor) and Rapamycin (mTOR inhibitor). …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto